Shopping Cart
- Remove All
Your shopping cart is currently empty
Rimegepant
🥰Excellent
Catalog No. T4610Cas No. 1289023-67-1
Alias BMS-927711, BMS927711, BMS 927711, BHV-3000
Rimegepant (BMS 927711) is a highly potent, oral calcitonin gene-related peptide (CGRP) receptor antagonist with a Ki value of 0.027 nM.
Rimegepant
🥰Excellent
Purity: 99.84%
Catalog No. T4610Alias BMS-927711, BMS927711, BMS 927711, BHV-3000Cas No. 1289023-67-1
Rimegepant (BMS 927711) is a highly potent, oral calcitonin gene-related peptide (CGRP) receptor antagonist with a Ki value of 0.027 nM.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | 47 € | In Stock | |
| 5 mg | 93 € | In Stock | |
| 10 mg | 153 € | In Stock | |
| 25 mg | 254 € | In Stock |
Bulk & Custom
Add to Cart
Questions
View MoreInhibitors Related to "Rimegepant"
Atogepant
MK8031. Atogepant, MK-8031, MK 8031, AGN-241689, AGN241689
T266821374248-81-3
Atogepant (MK-8031) is an orally available, selective and potent calcitonin gene-related peptide receptor (CGRP) antagonist for the study of migraine.
- 160 €
Size
QTY
HCGRP-(8-37) acetate
HCGRP-(8-37) acetate (119911-68-1 free base)
TP1134L
HCGRP-(8-37) acetate is a human calcitonin gene-related peptide (hCGRP) fragment acetate and also an antagonist of CGRP receptor.
- 163 €
Size
QTY
β-CGRP, human acetate
β-CGRP, human acetate (101462-82-2 free), Human β-CGRP acetate, CGRP-II (Human) (acetate)
TP2167
β-CGRP, human acetate is one of calcitonin peptides and acts via the complex of receptor-activity-modifying protein (RAMP) and calcitonin-receptor-like receptor (CRLR) (IC50s: 1 nM and 300 nM for CRLR/RAMP1 and CRLR/RAMP2 in cells).
- 362 €
Size
QTY
Calcitonin（salmon） Acetate(47931-85-1(free base))
Salmon calcitonin
TP1040L
Calcitonin(salmon)Acetate(47931-85-1(free base))(Salmon calcitonin) , a calcium regulating hormone, is used to treat osteoporosis in women who are at least 5 years past menopause.
- 91 €
Size
QTY
Vazegepant hydrochloride
Vazegepant HCl
T86821414976-20-7
Vazegepant hydrochloride (Vazegepant HCl) is the first intranasal gepant for the acute treatment of migraine and has announced a positive phase II/III study.
- 103 €
Size
QTY
Ubrogepant
MK-1602
T171941374248-77-7
Ubrogepant (MK-1602) is a calcitonin gene-related peptide receptor antagonist used in acute migraine treatment studies.
- 147 €
Size
QTY
CGRP antagonist 1
T134531123757-49-2In house
CGRP antagonist 1 is a potent CGRP receptor antagonist with Ki values of 35 nM and IC50 values of 57 nM, respectively.CGRP antagonist 1 can be used for the study of cardiovascular and neurovascular diseases.
- 324 €
Size
QTY
Galcanezumab
LY 2951742
T766821578199-75-3
Galcanezumab is a humanized IgG4 monoclonal antibody targeting the CGRP ligand, which binds to the ligand calcitonin gene-related peptide. Galcanezumab can be used to prevent and treat migraines or cluster headaches.
- 122 €
Size
QTY
Calcitonin (salmon)
Salmon calcitonin, Calcitonin salmon
TP104047931-85-1
Calcitonin (salmon), a calcium regulating hormone, is used to treat osteoporosis in women who are at least 5 years past menopause.
- 93 €
Size
QTY
Olcegepant
BIBN-4096, BIBN 4096BS
T12293L204697-65-4
Olcegepant (BIBN-4096) is an effective and selective non-peptide calcitonin gene-related peptide 1 (CGRP1) receptor antagonist (IC50 of 0.03 nM and Ki of 14.4 pM for human CGRP).
- 29 €
Size
QTY
Vazegepant
Zavegepant, BMS-742413, BHV-3500
T387341337918-83-8
Vazegepant (Zavegepant) is an orally available and selective antagonist of the calcitonin gene-related peptide CGRP receptor for pain relief and may be used in the study of migraine.
- 100 €
Size
QTY
CGRP 8-37 (rat)
TP1323129121-73-9
CGRP 8-37 (rat) is a CGRP receptor antagonist, a CGRP fragment with potential anti-injury effects that induces arterial relaxation.
- 273 €
Size
QTY
Select Batch
Purity:99.84%
Contact us for more batch information
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.Product Introduction
Bioactivity
Chemical Properties
| Description | Rimegepant (BMS 927711) is a highly potent, oral calcitonin gene-related peptide (CGRP) receptor antagonist with a Ki value of 0.027 nM. |
| Targets&IC50 | CGRP receptor:0.14 nM |
| In vitro | BMS-927711 is a full, competitive CGRP receptor antagonist with IC50 of 0.14±0.01 nM. |
| In vivo | The mean area under the curve (AUC) (0-24 h) ratios for BMS-927711 at dosages of 60, 100, and 300 mg/kg in the dried blood spot (DBS) matrix versus plasma range from 0.5-0.6 for all doses in rats, indicating a strong correlation between BMS-927711 concentrations in rat plasma and DBS. This study demonstrates that BMS-927711 possesses favorable oral bioavailability in both rats and cynomolgus monkeys, alongside promising preclinical attributes. Furthermore, it exhibits dose-dependent efficacy in a primate model of Calcitonin Gene-Related Peptide (CGRP)-induced facial blood flow, underscoring its potential therapeutic utility. |
| Alias | BMS-927711, BMS927711, BMS 927711, BHV-3000 |
| Molecular Weight | 534.56 |
| Formula | C28H28F2N6O3 |
| Cas No. | 1289023-67-1 |
| Smiles | N[C@H]1[C@@H](CC[C@@H](OC(=O)N2CCC(CC2)n2c3cccnc3[nH]c2=O)c2ncccc12)c1cccc(F)c1F |
| Relative Density. | 1.45 g/cm3 (Predicted) |
Storage & Solubility Information
| Storage | keep away from direct sunlight,keep away from moisture,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (93.53 mM)  Ethanol: <1 mg/mL (insoluble) | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Keywords
Preview
Related Tags: buy Rimegepant | purchase Rimegepant | Rimegepant cost | order Rimegepant | Rimegepant chemical structure | Rimegepant in vivo | Rimegepant in vitro | Rimegepant formula | Rimegepant molecular weight
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.